4.7 Letter

Multiecho MR Imaging and Proton MR Spectroscopy for Liver Fat Quantification

Journal

RADIOLOGY
Volume 249, Issue 3, Pages 1081-1081

Publisher

RADIOLOGICAL SOC NORTH AMERICA
DOI: 10.1148/radiol.2493081034

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab

Anthony Dohan, Benoit Gallix, Boris Guiu, Karine Le Malicot, Caroline Reinhold, Philippe Soyer, Jaafar Bennouna, Francois Ghiringhelli, Emilie Barbier, Valerie Boige, Julien Taieb, Olivier Bouche, Eric Francois, Jean-Marc Phelip, Christian Borel, Roger Faroux, Jean-Francois Seitz, Stephane Jacquot, Meher Ben Abdelghani, Faiza Khemissa-Akouz, Dominique Genet, Jean Louis Jouve, Yves Rinaldi, Francoise Desseigne, Patrick Texereau, Etienne Suc, Come Lepage, Thomas Aparicio, Christine Hoeffel

Article Oncology

Intra-arterial idarubicin_lipiodol without embolization can provide prolonged complete response in hepatocellular carcinoma: A case report

Pauline Pistre, Boris Guiu, Sophie Gehin, Mathieu Boulin

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)

Article Gastroenterology & Hepatology

Outcome after pancreatectomy for neuroendocrine neoplams according to the WHO 2017 grading system: A retrospective multicentric analysis of 138 consecutive patients

Regis Souche, Antoine Coignac, Marie Dupuy, Martin Bertrand, Isabelle Raingeart, Boris Guiu, Astrid Herrero, Fabrizio Panaro, Stephane Obled, Fabienne Portales, Benjamin Riviere, Jeanne Ramos, Frederic Borie, Francois Quenet, Pierre-Emmanuel Colombo, Michel Prudhomme, Eric Assenat, Jean-Michel Fabre

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Learning curve of liver stiffness measurement using a new hybrid machine composed of transient elastography interfaced with ultrasound

Christophe Cassinotto, Marie-Ange Pierredon-Foulongne, Ali Belgour, Julien Delicque, Laure Escal, Nicolas Molinari, Sophie Anselme, Tony Jacq, Ugo Chamard-Champliaud, Bastien Nicolan, Carole Allimant, Boris Guiu

EUROPEAN RADIOLOGY (2020)

Article Oncology

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma A Phase 2 Clinical Trial

Julien Edeline, Yann Touchefeu, Boris Guiu, Olivier Farge, David Tougeron, Isabelle Baumgaertner, Ahmet Ayav, Boris Campillo-Gimenez, Luc Beuzit, Marc Pracht, Astrid Lievre, Samuel Le Sourd, Karim Boudjema, Yan Rolland, Eveline Boucher, Etienne Garin

JAMA ONCOLOGY (2020)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Antiviral (Hepatitis C Virus) Drug-Drug Interaction Leading to Dramatic Underestimation of Liver Function With 99mTc-Mebrofenin Hepatobiliary Scintigraphy

Emmanuel Deshayes, Cyril Fersing, Lucy Meunier, Francois Quenet, Boris Guiu

CLINICAL NUCLEAR MEDICINE (2020)

Article Gastroenterology & Hepatology

Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs

Anita Paisant, Valerie Vilgrain, Jeremie Riou, Frederic Oberti, Olivier Sutter, Valerie Laurent, Agnes Rodes, Boris Guiu, Christophe Cassinotto, Herve Trillaud, Ivan Bricault, Sophie Michalak, Onorina Bruno, Maxime Ronot, Christophe Aube

JOURNAL OF HEPATOLOGY (2020)

Article Oncology

Oncological Outcomes after Liver Venous Deprivation for Colorectal Liver Metastases: A Single Center Experience

Salah Khayat, Gianluca Cassese, Francois Quenet, Christophe Cassinotto, Eric Assenat, Francis Navarro, Boris Guiu, Fabrizio Panaro

Summary: This study presents the oncological outcomes of Liver Venous Deprivation (LVD) in 17 patients with Colorectal Liver Metastases, showing comparable 1-year and 3-year overall survival rates to Portal Vein Embolization (PVE). Although postoperative complications were observed in 47% of patients, there were no deaths, and hepatic recurrence rate was 52.9%.

CANCERS (2021)

Article Medicine, General & Internal

Deportalization, Venous Congestion, Venous Deprivation: Serial Measurements of Volumes and Functions on Morphofunctional 99mTc-Mebrofenin SPECT-CT

Lauranne Piron, Emmanuel Deshayes, Christophe Cassinotto, Francois Quenet, Fabrizio Panaro, Margaux Hermida, Carole Allimant, Eric Assenat, Georges-Philippe Pageaux, Nicolas Molinari, Boris Guiu

Summary: The study found that liver volume and function progress independently regardless of vascular conditions. Hepatic congestion from outflow obstruction drives volume increase but also results in early impaired function.

DIAGNOSTICS (2021)

Article Oncology

Uni-, Bi- or Trifocal Hepatocellular Carcinoma in Western Patients: Recurrence and Survival after Percutaneous Thermal Ablation

Ancelin Preel, Margaux Hermida, Carole Allimant, Eric Assenat, Chloe Guillot, Cecilia Gozzo, Serge Aho-Glele, Georges-Philippe Pageaux, Christophe Cassinotto, Boris Guiu

Summary: The study found that in Western patients, bi- and trifocal HCC significantly increased the risk of distant recurrence, especially very early recurrence. Overall survival after PTA of trifocal HCC was significantly below what was expected after curative treatment.

CANCERS (2021)

Article Chemistry, Medicinal

Anticancer Drugs for Intra-Arterial Treatment of Colorectal Cancer Liver Metastases: In-Vitro Screening after Short Exposure Time

Audrey Fohlen, Karim Bordji, Eric Assenat, Celine Gongora, Celine Bazille, Jeremy Boulonnais, Mikael Naveau, Cecile Breuil, Elodie A. Peres, Myriam Bernaudin, Boris Guiu

Summary: This study investigated the response of different cell lines to 12 cytotoxic agents, finding that idarubicin was the most cytotoxic to most colorectal cancer cell lines, while gemcitabine was most effective for certain cell lines. Interestingly, commonly used cytotoxic agents in the treatment of colorectal liver metastases showed limited cytotoxicity in the tested cell lines.

PHARMACEUTICALS (2021)

Article Oncology

Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma

Marie Cantaloube, Florence Castan, Morgane Creoff, Jessica Prunaretty, Karl Bordeau, Morgan Michalet, Eric Assenat, Boris Guiu, Georges-Philippe Pageaux, Marc Ychou, Norbert Ailleres, Pascal Fenoglietto, David Azria, Olivier Riou

Summary: The study demonstrates that stereotactic body radiation therapy (SBRT) using volumetric modulated arc therapy (VMAT) and real-time adaptive tumor gating for hepatocellular carcinoma (HCC) is effective with optimal local control and low toxicity, especially in patients not eligible for other local therapies. Additionally, the diameter of lesions and the volume of PTV were found to be associated with disease-free survival and overall survival in HCC patients receiving SBRT with VMAT.

CANCERS (2021)

Article Medicine, General & Internal

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study

Karl Bordeau, Morgan Michalet, Aicha Keskes, Simon Valdenaire, Pierre Debuire, Marie Cantaloube, Morgane Cabaille, William Jacot, Roxana Draghici, Sylvain Demontoy, Xavier Quantin, Marc Ychou, Eric Assenat, Thibault Mazard, Ludovic Gauthier, Marie Dupuy, Boris Guiu, Celine Bourgier, Norbert Ailleres, Pascal Fenoglietto, David Azria, Olivier Riou

Summary: Liver stereotactic body radiotherapy (SBRT) provides effective local control and minimal toxicity for liver metastases. This study presents the first clinical results of stereotactic MR-guided radiotherapy (MRgRT) for liver metastases from a prospective registry. The treatment was well-tolerated, with low rates of acute and late toxicities. The overall survival and local control rates were promising, but distant relapse remains a challenge.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

Prolonged Survival after Recurrence in HCC Resected Patients Using Repeated Curative Therapies: Never Give Up!

Cyprien Toubert, Boris Guiu, Bader Al Taweel, Eric Assenat, Fabrizio Panaro, Francois-Regis Souche, Jose Ursic-Bedoya, Francis Navarro, Astrid Herrero

Summary: Surgical resection is the optimal treatment for hepatocellular carcinoma (HCC), but recurrence is common. This retrospective study analyzed survival after HCC recurrence following liver resection. The time and type of recurrence treatment were found to be major prognostic factors. However, overall survival did not significantly differ between patients who experienced recurrence and those who did not after receiving curative treatment.

CANCERS (2023)

Article Oncology

Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas

Camille Goislard de Monsabert, Yann Touchefeu, Boris Guiu, Boris Campillo-Gimenez, Olivier Farges, David Tougeron, Isabelle Baumgaertner, Ahmet Ayav, Luc Beuzit, Marc Pracht, Astrid Lievre, Samuel Le Sourd, Karim Boudjema, Yan Rolland, Etienne Garin, Eveline Boucher, Julien Edeline

Summary: The combination of selective internal radiotherapy (SIRT) and chemotherapy with cisplatin and gemcitabine as first-line treatment for unresectable intrahepatic cholangiocarcinomas (ICCs) was found to maintain patients' quality of life (QoL). Although there were no clinically significant changes in the global health score or QoL sub-scales during follow-up, some functional and symptom scores worsened during treatment.

CURRENT ONCOLOGY (2021)

No Data Available